ConductScience.org, home

Trial · NCT07771556

7-Day Caffeine and Upper-Body Power in Active Women

NCT07771556, Not applicable, Completed, Birjand University of Medical Sciences

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. 7-Day Caffeine and Upper-Body Power in Active Women. Trials, record NCT07771556. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07771556

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
7-Day Caffeine and Upper-Body Power in Active Women
NCT number
NCT07771556
Status
Completed
Phases
Not applicable
Enrollment
30 participants, actual
Lead sponsor
Birjand University of Medical Sciences
Conditions
Caffeine, Exercise, Physical Fitness
Interventions
Caffeine, Placebo
First posted
2026-08-18
Last updated
2026-08-18

Source ClinicalTrials.gov

Registered outcomes8

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in Upper-Body Peak Anaerobic PowerMeasured 90 minutes post-ingestion on Day 1 and Day 7.Peak power output (W·kg-¹) measured during a 20-second upper-body Wingate test on a cycle ergometer (Monark 891 E).
SecondaryChange in Cognitive PerformanceMeasured at baseline, 90 minutes post-ingestion, and 30 minutes post-exercise on Day 1 and Day 7.
Cognitive performance assessed using the Golden Stroop Test (color-word interference task). The score represents the number of correct responses in the third part of the test (incongruent condition) within 45 seconds.
SecondaryChange in RMSSDMeasured at baseline, 90 minutes post-ingestion, and 30 minutes post-exercise on Day 1 and Day 7.Root mean square of successive differences (ms) measured using a Polar H10 heart rate sensor.
SecondaryChange in SDNNMeasured at baseline, 90 minutes post-ingestion, and 30 minutes post-exercise on Day 1 and Day 7.Standard deviation of normal-to-normal intervals (ms) measured using a Polar H10 heart rate sensor.
SecondaryChange in LF PowerMeasured at baseline, 90 minutes post-ingestion, and 30 minutes post-exercise on Day 1 and Day 7.Low-frequency power (ms²) measured using a Polar H10 heart rate sensor.
SecondaryChange in HF PowerMeasured at baseline, 90 minutes post-ingestion, and 30 minutes post-exercise on Day 1 and Day 7.High-frequency power (ms²) measured using a Polar H10 heart rate sensor.
SecondaryChange in LF/HF RatioMeasured at baseline, 90 minutes post-ingestion, and 30 minutes post-exercise on Day 1 and Day 7.Ratio of low-frequency to high-frequency power (dimensionless) measured using a Polar H10 heart rate sensor.
SecondaryChange in Total Power (TP)Measured at baseline, 90 minutes post-ingestion, and 30 minutes post-exercise on Day 1 and Day 7.Total power (ms²) measured using a Polar H10 heart rate sensor.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests1

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed as
Stroop Color-Word TestSecondary outcome

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07771556

GET https://conductscience.org/api/trials/v1/NCT07771556/registered